Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
Go back to Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results| (NASDAQ: AMLX) | Delayed: 39.14 +0.54 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.60 | 52 Week High | $ | |||
| Open | $37.49 | 52 Week Low | $ | |||
| Day High | $39.93 | P/E | N/A | |||
| Day Low | $37.37 | EPS | $ | |||
| Volume | 2,072,553 | |||||

